PDCD1 and ductal breast carcinoma in situ: We thereby add to the current knowledge and put forth a specific immune gene signature for basal-like DCIS from immune cells identified in C3Tag DCIS that is loss of PD1+ immune cells as a marker of possible progression, and support more studies in this regard to study immune-epithelial relationships with more spatial methods.